The ISBER Global Biobanking Congress has been the premier event in biobanking education for over 25 years and is the only truly global event in biobanking. Year after year, ISBER brings together new and returning biobankers from 6 continents,
providing opportunities for academia, industry, and pharma to learn, connect, discuss, and collaborate.
"I attend ISBER Meetings because I found them to be an impactful venue with lots of networking opportunities and engagement with other friendly biobankers/researchers from around the world willing to share their own personal challenges and success."
2026 World Biobanking Congress
April 21 - 25, 2026
in partnership with ISBER, BBCMBA, and BGI
Registration
World Biobanking Congress 2026
ISBER is proud to partner with the Biobank Branch, China Medicinal Biotech Association (BBCMBA) and BGI for the World Biobanking Congress 2026 taking place April 21st through April
25th, 2026, in Shenzhen, China. This landmark event represents an exceptional collaboration between the three prominent leading biobanking associations. This stimulating educational five-day event will be hosted
at the BGI Group’s global headquarters.
The World Biobanking Congress 2026 will feature two significant international gatherings. First, the 2026 ISBER Global Biobanking Congress: Global Collaboration for Advanced Technology and Innovation will take place from April 21st to 23rd at the BGI Center. Following this, the BBCMBA 18th China Holistic Integrate Biobankology Conference and the 13th Hospital Dean’s Summit on Biobank are scheduled for April
23rd to 25th at the InterContinental Shenzhen Dameisha Resort. The BBCMBA congress is delivered in Chinese only.
A key highlight of the congress will be the collaborative day on April 23rd, hosted at the BGI Center. This joint day will serve as a central platform for fostering international partnership, promoting shared learning,
and driving innovation within the global biobanking community.
A joint letter from the Presidents of the participating organizations can be read here.
Details for the ISBER Global Biobanking Congress can be found on this page.
Theme: Global Collaboration for Advanced Technology and Innovation
Format: In-person only, at the BGI Center, Shenzhen, China
Days: April 21-23, 2026
Language: English
Registration: Open with Early Bird registration rates. Extended deadline: Jan. 31, 2026
You may register to attend the ISBER Global Biobanking Congress (April 21–23), or select a combined registration to attend both the ISBER Congress (April 21-23) and the BBCMBA Congress (April 23-25) using the registration link
below. Chinese nationals are encouraged to register through our partner’s website. The BBCMBA registration website can be accessed here.
*Student/Technician: If you are not a current ISBER student or technician member, please submit proof of your student status or a letter from your employer to info@isber.org to receive the student & technician rate.
**Joint Congresses Bundle Package: Attend both the ISBER Global Biobanking Congress (April 21-23) and the BBCMBA China Integrated Biobank Congress (April 23-25) for a discounted price. Purchase your pass to ISBER and get a $200 pass to the BBCMBA congress. The bundle price will be available upon purchase of the ISBER pass, in the registration platform. Please note that the BBCMBA's congress is delivered in Chinese.
IMPORTANT INFORMATION FOR PARTICIPANTS FROM CHINA
Please note that ISBER is an international organization with no establishment in the People’s Republic of China (PRC), therefore, registration prices are exclusive of any applicable taxes or fees such as income tax and VAT. In accordance with PRC law, all such taxes and fees are the sole responsibility of the payer, who shall be liable for withholding and remitting the relevant VAT and income tax in addition to the registration fee. Chinese participants who are able to complete payment directly through this website are required to pay the applicable taxes on their invoices. ISBER是⼀家在中国未设机构场所的国际组织。以上价格不包含任何依照中国法律所可能需要征收的例如企业所得税、增值税等类型的税费。该等税费由付款⼈在以上价格之外，另⾏单独承担并代扣代缴。
Chinese nationals are encouraged to register through our partner's website. BBCMBA's registration website can be accessed here.
WHAT'S INCLUDED WITH YOUR REGISTRATION PASS?
Full Conference Registration:
Access to Sessions & Exhibition on all days of the meeting, in Shenzhen, China on April 21-23, 2026
Coffee/Tea & lunch breaks
Access to the Welcome Reception on Day 1, including one drink ticket
Access to the Exhibitor Reception on Day 2, including one drink ticket
Access to the full joint day with BBCMBA, on Day 3
Reduced bundle price to join both the ISBER congress (April 21-23, 2026) and the BBCMBA meeting (April 24-25, 2026)
Opportunity to customize your networking schedule with add-on activities (site visit, speed networking, scenic run/walk with the famous ISBER t-shirt, social evening) available at a reduced cost.
ADD-ON ACTIVITIES
The ISBER Global Biobanking Congress offers several fun, networking activities that are not included with your registration but can be purchased or signed up for during registration. Don't miss out!
Biobank Site Visits - Monday, April 20, 2026, throughout the day | FREE
Delegates will have the opportunity to visit the BGI Center in Shenzhen, one of the world’s leading genomics research facilities and the venue of the 2026 ISBER Congress. This site visit offers attendees a firsthand
look at cutting-edge innovations in genomics, sequencing, and biobanking technologies, providing valuable insights and inspiration for advancing their own research and repository practices.The site visits
are complimentary to registered delegates and will be held during the pre-congress day: Monday, April 20, 2026. Delegates may sign up for a tour time when registering for the congress(es). Sign up is mandatory.
Whether you're new to the ISBER meeting or a returning attendee, start this Congress right, with our popular Speed Networking event! Join fellow biobankers and delegates for lively one-on-one conversations in
five-minute intervals, all while enjoying local delicacies and hot beverages. It’s the perfect chance to make connections, spark collaborations, and meet peers from around the globe in a relaxed, fun setting.
Sign up for the speed networking when registering or purchase a ticket
by clicking here.
Scenic Run/Walk - Thursday, April 23, 2026, 6:00am to 7:00am | FREE
This year, delegates are invited to enjoy a self-paced run or walk along a picturesque beachwalk path recommended by the local organizers, offering scenic views of the water on one side and the vibrant city
on the other. The Fun Run/Walk is a free, self-reliant activity designed to bring ISBER and BBCMBA delegates together for a fun outdoor networking experience; A refreshing start to the joint ISBER-BBCMBA
day! Participants can purchase a collectible ISBER athletic t-shirt, featuring the iconic dancing ISBER letters customized with local emblems, celebrating the spirit and energy of our host country. Order
your t-shirt when registering or purchase it
by clicking here before March 10.
LOW & MIDDLE INCOME COUNTRIES DISCOUNTED REGISTRATIONS
Delegates in countries identified by the World Bank as Low Income (LICs), Lower-Middle Income (LMICs), and Upper-Middle Income (UMICs) are eligible for discounted registrations of 75%, 50%, and 25% respectively. If you are eligible to receive a discount, please contact info@isber.org.
To confirm the income classification for your country, please
click here.
Please note that if you are also a technician or student, you will receive only the LIC/LMIC/UMIC discount or the technician/student discount, whichever discount is higher.
REGISTRATION TERMS & CONDITIONS
Registration Fees deadline Early registrations will be accepted until January 31, 2026 at midnight Pacific Standard Time (PST). Should your registration remain unpaid on February 1, 2026, early registrations will be upgraded to the regular registration fee. As of February 1, 2026, and until the conference days, regular registration fees apply for every new registration. Registration Modification & Cancellation A $75 USD administrative fee will be applied to any cancellations. The last day to cancel your registration and receive a refund (minus the $75 cancellation fee) is January 31, 2026. After this date, no refunds will be possible, however name changes are accepted.
If a badge is lost or forgotten onsite, an administrative fee of $100 USD will be charged for the reprint of the badge after identity verification (passport, driving license or other recognized identification documents).
Add-on Activities Modification & Cancellation For cancellations received prior to January 31, 2026, midnight PST, amounts will be refunded less a $15 USD administrative fee. After this date, no refunds will be possible.
Please note that ISBER is an international organization with no establishment in the People’s Republic of China (PRC), therefore, registration prices are exclusive of any applicable taxes or fees such as income tax and VAT. In accordance with PRC law, all such taxes and fees are the sole responsibility of the payer, who shall be liable for withholding and remitting the relevant VAT and income tax in addition to the registration fee. Chinese participants who are able to complete payment directly through this website are required to pay the applicable taxes on their invoices. ISBER是⼀家在中国未设机构场所的国际组织。以上价格不包含任何依照中国法律所可能需要征收的例如企业所得税、增值税等类型的税费。该等税费由付款⼈在以上价格之外，另⾏单独承担并代扣代缴。
Registration for Chinese Nationals may be completed through the BBCMBA partner's website and onsite at the venue, where onsite rates will apply as per the congress’ terms and conditions. Chinese Nationals can purchase an ISBER-only pass or the bundle pass to join both ISBER and BBCMBA's congresses on the BBCMBA's website.
The ISBER Global Biobanking Congress offers several fun, networking activities that are not included with your registration but can be purchased or signed up for during registration. Don't miss out!
Biobank Site Visits - Monday, April 20, 2026, throughout the day | FREE
Delegates will have the opportunity to visit the BGI Center in Shenzhen, one of the world’s leading genomics research facilities and the venue of the 2026 ISBER Congress. This site visit offers attendees a firsthand
look at cutting-edge innovations in genomics, sequencing, and biobanking technologies, providing valuable insights and inspiration for advancing their own research and repository practices. The site visits are complimentary
to registered delegates and will be held during the pre-congress day: Monday, April 20, 2026. Delegates may sign up for a tour time when registering for the congress(es). Sign up is mandatory.
Attendees with a site visit ticket will receive details about the meeting point and schedule closer to the event date.
Whether you're new to the ISBER meeting or a returning attendee, start this Congress right, with our popular Speed Networking event! Join fellow biobankers and delegates for lively one-on-one conversations in five-minute
intervals, all while enjoying local delicacies and hot beverages. It’s the perfect chance to make connections, spark collaborations, and meet peers from around the globe in a relaxed, fun setting. Sign up for the
speed networking when registering or purchase a ticket here:
Scenic Run/Walk - Thursday, April 23, 2026, 6:00am to 7:00am | FREE
This year, delegates are invited to enjoy a self-paced run or walk along a picturesque beachwalk path recommended by the local organizers, offering scenic views of the water on one side and the vibrant city on the other.
The Fun Run/Walk is a free, self-reliant activity designed to bring ISBER and BBCMBA delegates together for a fun outdoor networking experience; A refreshing start to the joint ISBER-BBCMBA day! Participants can
purchase a collectible ISBER athletic t-shirt, featuring the iconic dancing ISBER letters customized with local emblems, celebrating the spirit and energy of our host country. Order your t-shirt when registering
or purchase it here:
All times are listed in China Standard Time (CST).
Pre-Congress Day, MONDAY, April 20
Networking
BGI Site Visits
Delegates will have the opportunity to visit the BGI Center in Shenzhen, one of the world’s leading genomics research facilities and the venue of the 2026 ISBER Congress. This site visit offers attendees a firsthand
look at cutting-edge innovations in genomics, sequencing, and biobanking technologies, providing valuable insights and inspiration for advancing their own research and repository practices. The site visits are
complimentary to registered delegates and will be held during the pre-congress day: Monday, April 20, 2026. Delegates must sign up for a tour time when registering for the congress(es). Attendees with a site
visit ticket will receive details about the meeting point and schedule closer to the event date.
TUESDAY, April 21
Breakfast Corporate Sessions CONCURRENT
8:15am - 9:15am
Interested in delivering an educational session to the global biobanking audience? Check out the 2026 ISBER Prospectus.
9:30am - 9:45am
ISBER 2026 Welcome Address
Dr XU Xun, BGI, China Gregory Grossman, Advancing Sight Network/Precision Ocular Biobank, USA
KEYNOTE LECTURE
9:45am - 10:45am
AI-Powered Biobanking: Leveraging Machine Learning for Multi-Omics Insight, Prof CHEN Wan-Tao, MD, PhD, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, China
As biobanks evolve from static repositories into dynamic engines for biomedical discovery, they face the critical challenge of integrating and analyzing complex, high-dimensional multi-modal data derived from biospecimens.
Genomic, proteomic, metabolomic, and pathology imaging datasets are often fragmented, inconsistently annotated, and analytically siloed, which severely curtails their translational potential for advanced disease
research. We thus propose "AI-powered biobanking" as an essential conceptual and operational paradigm shift to overcome these limitations. This approach embeds artificial intelligence and machine learning not
as peripheral tools but as integral components of the biobank's scientific infrastructure. By leveraging AI to model complex relationships across multi-omics layers, pathology images, and clinical variables,
biobanks can synthesize heterogeneous data into coherent and interpretable knowledge. Central to this vision is the deployment of computational methods that facilitate scalable integration, automated quality
assessment, and the extraction of robust predictive signals from large-scale biobank cohorts. Such capabilities empower biobanks to transcend their traditional role as data storage facilities and become active
contributors to hypothesis generation and biomarker discovery. The success of this model hinges on the close alignment of computational innovation with rigorous biobanking practices and clinically grounded research
questions. AI-powered biobanking, therefore, represents a strategic reorientation that redefines the biobank's role in the data-driven future of biomedical research, ensuring that biospecimen collections are
intrinsically linked to intelligent, integrative analytics.
AI-Driven Framework for Full-Lifecycle Management of Biobank Dry Repositories Jingjing Jiang, Jingwei Zhiyun (Beijing) Technology, China
AI-Powered Biobanking: Leveraging Machine Learning for Multi-Omics Insights Wan-Tao Chen, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, National Center
for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Research Institute of Stomatology, Shanghai Professional Technical Service Platform, China
An AI Assessment Model for Cancer Tissues Frozen H&E Sections before Distribution in Biobanks Menghong Sun, Fudan University Shanghai Cancer Center, China
Design and Preliminary Implementation of an AI-Based Intelligent Management System for Biobanks Midie Xu, Fudan University Shanghai Cancer Center, China
Fulfilling the Promise of Biobanks for Innovation in Africa's Technological Era Kossi Fofo KABO, Institut Pasteur de Dakar, Senegal
SESSION 2 - Ethical, Legal, Social Implications (ELSI)
A MBirSA Statement On Benefit Sharing In Biobanking In South Africa Ciara Staunton, University of KwaZulu-Natal, South Africa
A Study on the Sharing Mechanism under the General Hospital Biobanks from the Perspective of the Principle of Solidarity Yuqing Ji, Huashan Hospital Fudan University, China
Consent in Biobanks in Europe and Worldwide: Models, Challenges, and Future Directions Judita Kinkorova, University Hospital Pilsen, Czechia
To Favour Caution or Consent? Insights From Those Consenting to Biobanking at End of Life: Considerations for Clinical Teams Cassandra Griffin, The University of Newcastle, The University of
Newcastle Hunter Medical Research Institute, Australia
12:30pm - 1:00pm
General lunch in the Exhibit Hall
Corporate Sessions CONCURRENT
1:00pm - 1:45pm
Interested in delivering an educational session to the global biobanking audience? Check out the 2026 ISBER Prospectus.
Development of a Community-Based Natural Population Cohort Biobank of Mental Disorders Xiaojie Zhang, The Second Xiangya Hospital of Central South University, China
Goodbye Yellow Brick Road: Treading a New Path to Biobank Sustainability With Demonstrated Cost-Recovery Cassandra Griffin, The University of Newcastle, The University of Newcastle Hunter Medical
Research Institute, Australia
Integrating an ISO 20387-Certified Biobank with a Comprehensive Clinical Database to Power Research in a Large Pediatric Liver Transplantation Cohort Xiaonan KANG, Shanghai Jiao Tong University,
China
Integrating Genomics into Indonesia’s National Health Survey: Technical Insights from the BGSI Central Biobank Ines Irene Atmosukarto, Kementerian Kesehatan Republik Indonesia, Indonesia
Scaling Newborn Screening and Biobank Integration for Early Child Health Interventions in South Africa Engela Helena Conradie, North-West University, South Africa
Toward a Maturity Model: Foundational Findings for Evaluating Trusted Research Environments in Federated Analytics Networks Jasper Hoi Chun Luong, The University of British Columbia, Macao
Establishing a Pathology Archive Within a Tribal Health Organization Abbie Willetto, Alaska Native Tribal Health Consortium, United States
The ISBER Mentoring Program, A New Online Resource For Your Biobank Staff Marianne Henderson, National Cancer Institute, International Society for Biological and Environmental Repositories,
United States
SESSION 4 - Biospecimen Research - The Science Behind the Sample
Morphology-Guided Zonal Sampling Protocol for Colorectal Cancer: A Histology-Based Strategy to Enhance Biobank Specimen Quality Weiwei Jing, Fudan University Shanghai Cancer Center, China
A Comparative Evaluation of Different Cooling Strategies for Cryopreserving Mouse Liver Tissue: Assessing Viability, Structure, Metabolism, and Regenerative Potential Jinlian Pei, Medical Innovation
Research Department of PLA General Hospital, China
Development of Advanced Vitrification Solutions through the Application of Macromolecules: A Case Study Using PVP Ruidong Ma, Northeastern University, University of Washington, United States
Industry Clinical Trial Samples In Long-Term Storage: A Quality And Stability Study By Takeda Pharmaceutical’s Biobank Shannon Chan, Takeda Development Center Americas Inc, United States
A Biobanking Legacy: The Impact of Post-Mortem Biobanking Programs Weiye Charles Wang, Shanghai Biochip Center (SBC), National Engineering Research Center, China
The GenV Biobank: Powering Biological Research in a Large Longitudinal Cohort of Australian Newborns and Their Parents Richard Saffery, Murdoch Children's Research Institute, Australia
Biobanking for Booroolongs: Investigating the Effect of Bovine Serum Albumin (BSA) and Caffeine on Post-Thaw Sperm Motility in a Threatened Frog Species Zara Melrose Anastas, University of
Wollongong Faculty of Science Medicine and Health, Australia
Determination Of Biocontainment Levels For Biobanked Samples – A South African Case Study Puseletso Johnston, Agricultural Research Council, South Africa
4:00pm - 4:30pm
Afternoon Break
Getting to Know ISBER
4:30pm - 5:30pm
Getting to Know ISBER Whether you are new to ISBER, a long-time member or considering to become a member, join us in this session to learn more about the Society and to ask questions!
Presentation of the Education & Training, Standards, and Science Policy Communities of Practice
Networking
5:30pm - 7:00pm
Welcome Reception
Join us for a networking evening in the exhibit hall where you can connect with colleagues and exhibitors, and peruse the abstract posters. Poster presenters will be at their posters to network with delegates.
WEDNESDAY, APRIL 22
Networking
7:30am - 9:00am
Speed Networking Activity (Registration required) Hosted by Program Planning Task Force Members: Jelani Clarke, Henry Hong, and Wayne Wang
Whether you're new to the ISBER meeting or
a returning attendee, join fellow biobankers and delegates for lively one-on-one conversations in five-minute intervals, all while enjoying local delicacies and hot beverages. It’s the perfect chance to make connections,
spark collaborations, and meet peers from around the globe in a relaxed, fun setting. Sign up for the speed networking when registering.
KEYNOTE LECTURE
9:00am - 10:00am
Turning Biobanks into Clinical Engines: Pharma’s Translational Medicine and Diagnostic, Dr SU Xinying, MD, PhD, Development China, Pfizer, China
In clinical-stage drug development, translational medicine and diagnostics are pivotal for patient stratification, biomarker validation, and regulatory success. High-quality biobank samples linked to clinical and
multi-omics data enable pharma to bridge discovery and application, reducing trial failure and accelerating precision medicine.Pharma-led integration of biobanking with translational medicine transforms biobanks
into strategic engines for clinical development. This approach drives precision diagnostics, regulatory compliance, and patient-centric innovation.
SESSION 5 - Biospecimen Research - The Science Behind the Sample
A resource of paired CSF and serum in neuroimmune diseases: strategies for micro-volume biospecimen management Xiangjun Chen, Huashan Hospital Fudan University, China
A Serum Metabolomics Signature for Early Detection and Molecular Stratification in Head and Neck Squamous Cell Carcinoma Hexin Ma, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University
School of Medicine, China
Integrated Antioxidant, Nanoparticle, And Antifreeze Protein Strategies Synergistically Enhance Cryotop Vitrification Outcomes of Porcine Parthenogenetic Embryos Xueming Zhao, Chinese Academy
of Agricultural Sciences, China
Iterative Orthotopic Mouse Models for Generating Phenotype-Defined Biospecimens and Matched Datasets in Hepatocellular Carcinoma Metastasis Research Kai Jiang, Shanghai Jiao Tong University
School of Medicine Affiliated Renji Hospital, China
Nationwide Genotype-Resistance Landscape of Wickerhamomyces anomalus in China and Genomic Decoding of the First Pan-Resistant Clinical Isolate Tianshu Sun, Peking Union Medical College Hospital,
China
Living Biobanks of Liver Organoids: Valuable Resource for Drug Safety Assessment Shuyu Gong, Children's Hospital of Shanghai, China
SESSION 6 - Bench to Biobank to One Health
Transforming Biobanking Operations: A Case Study on the Integration and Impact of a Fully Automated -80°C Storage System at the MUB Biobank Anna Michalska-Falkowska, Uniwersytet Medyczny w
Bialymstoku, Medizinische Universitat Graz, Poland
Advancing Regional Biobanking and Biosafety Governance in ASEAN: From Feasibility to Policy and Global Alignment Jasper Hoi Chun Luong, Smoke-Free and Healthy Life Association of Macau, Macao
Development of The First National Human Biospecimen Proficiency Testing Program by The Thailand Biobank Consortium Chawanit Wongkasa, Ramathibodi Comprehensive Cancer Center, Faculty of Medicine
Ramathibodi Hospital, Mahidol University, Thailand
Indonesia’s Biobank Network for Precision Medicine and Population Genomics: First National Biobank Infrastructure Indri Rooslamiati Supriadi, Kementerian Kesehatan Republik Indonesia, Indonesia
From Data Fragmentation to Integration: Developing the Pathogenic Variant Database (CRDPVD) of the National Rare Disease Biobank of China Yiran Zhang, Peking Union Medical College Hospital,
China
Machine Learning-based Prediction of Antimicrobial Resistance in Klebsiella Pneumoniae Using Whole Genome Sequence Data Jingjia Zhang, Peking Union Medical College Hospital, China
Workshop 1 - Biobanking: Meeting the Needs of Downstream Research This workshop explores how modern biobanking practices can better serve today's and future research needs. Aimed at biobank
professionals, researchers, and managers, the session covers the full biospecimen lifecycle, from pre-analytical variables, collection workflows, quality assurance, data integration, and interoperability. Participants
will learn how upstream biobank decisions influence downstream experimental reliability and compatibility with new analytical platforms. Through real-world case studies, the workshop highlights practical strategies
to reduce research waste, enhance specimen and data integrity, and adapt operations to diverse research demands while maintaining ethical compliance and sustainability. Attendees will gain practical insights
to align biobanking with evolving scientific demands and improve research outcomes.
Presenters:
Karine Sargsyan, Cedars-Sinai Medical Center, United States
Anna Michalska-Falkowska, Medical University of Bialystok, Poland
Zisis Kozlakidis, International Agency for Research on Cancer, World Health Organization, France
Denis Marino, Cedars-Sinai Medical Center, United States
Workshop 2 - Integration of Multi-omics and Multimodal Data This 90-minute workshop, Integration of Multi-Omics and Multimodal Data, proposed for ISBER 2026, focuses on practical strategies
for integrating and standardizing high-throughput multi-omics and multimodal data. The session includes brief expert presentations on integration methods and real-world applications, followed by interactive
polling and group discussions. Participants will share challenges, exchange experiences, and explore best practices for data harmonization, reproducibility, and translational research, concluding with key takeaways
and future perspectives.
Presenters:
Zhang Zhen, Shanghai Ninth People's Hospital & College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Research Institute of Stomatology and Shanghai Key Laboratory of Stomatology,
China
Implementing a Research-Driven, Fully Digital Biobanking System: Experience from the Second Affiliated Hospital Biobank, Nanchang University Yun Yi, The Second Affiliated Hospital of Nanchang
University, China
Integrated Image Repository for Breast Tissue Biobank: Enabling Translational Research Madhura Kulkarni, Prashanti Cancer Care Mission Pune, India
Intelligent biobank supports the construction of Shanghai natural population cohort project Ping Xiao, Shanghai Municipal Center for Disease Control and Prevention, China
Label-free Intelligent Assessment of Organoid Viability and Its Applications Ruixin Yang, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, China
SESSION 8 - People, Policy & Biobanking
Audit Update on Breast Tissue Biobank Set-up from a Single Institutional Cohort in an LMIC Laleh Busheri, Prashanti Cancer Care Mission, Prashanti Cancer Care Mission Pune, India
Construction and Operation of the Biobank at Peking University People's Hospital: A Comprehensive Practice for Standardized Biomedical Resource Preservation Yujun Zhang, Peking University,
China
Construction of Patient-Derived Organoid-Based Living Biobank in a Gerenal Public Hospital: Key Strategies and Early–Stage Experiences Yi Zhang, Zhongshan Hospital Fudan University, China
Returning Incidental Findings in Biobanking: Genes Identified and Return-to-Patient Procedures Priyanka Seenauth, University Health Network, Canada
Distinctive Features on Building the Huashan Hospital Fudan University BioBank Jingsong Wu, Huashan Hospital Fudan University, China
Quantitative Analysis of EGFR Protein Expression Levels in Oral Squamous Cell Carcinoma Based on U-Net and ResNet34 Mengxuan Du, Department of Oral and Maxillofacial-Head and Neck Oncology,
Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Research Institute of Stomatology,
Sharing Platform for the Tissue Sample and Bioinformatics Database of Oral Maxillofacial Tumor, Shanghai Professional Technical Service Platform, China
The Analysis of Ethical Issues in AI-Based Organoid Biobanks Qian Li, Children's Hospital of Shanghai, China
Exploration and Reflection on the Construction of Unmanned Biobanks Wei Liang, Shanghai Clinical Research and Trail Center, China
SESSION 10 - Innovative Technology in Biobanking
Enhancing Perceived Data Security in an In-House Developed Biobank Laboratory Information Management System: Insights from a Multi-Stakeholder Workshop Lutfan Lazuardi, Universitas Gadjah
Mada, Indonesia
Bridging the Automation Gap: A Benchmark Review and Modular Approach to Accessible Tube Handling in Biobanking Bernal Cortes, Labot, Costa Rica
Establishing A U.S. Biobank Within A Global Network: Considerations For Aligning Legacy Human Samples to International Governance Standards Razan Humeida, AstraZeneca Pharmaceuticals LP,
United States
'Establishing A Virtual Repository, The Biobank Of The Future Daniel Kelly, ARK Repository, United States
Round Table Discussions CONCURRENT with Educational Workshop 3
5:15pm - 6:15pm
Roundtable Discussions
Innovating Biobanks for Spatial Transcriptomics Research | Juhi Tayal, Rajiv Gandhi cancer Institute and Research centre, India
Community-Centered Biobanking: Lessons from Global South Leadership and Adaptations for Pandemic Response | Helen Storey, PATH, United States
From Custodians to Catalysts: An Intensification Strategy for Academic Biobanks | Karine Sargsyan, Cedars Sinai, United StatesDefining the End-of-Life: Establishing a Framework for Biobank Collection Expiration
| Denis Marino, Cedars Sinai, United States
Workshop 3 - The Hidden Dangers of Selecting Long-Term Storage Labware This workshop provides a rare, deeply practical look into how engineering principles can, and should, inform decisions
about long-term storage consumables. Attendees will gain a practical framework for evaluating long-term storage labware, learn how small manufacturing variations translate into large operational risks,
and understand how to incorporate engineering-grade assessments into procurement decisions. The workshop empowers biobanking and laboratory professionals to balance cost pressures with robust quality assurance,
ultimately safeguarding sample integrity and advancing ISBER's mission of high-quality, reproducible biobanking practices.
Presenters:
Leigh Carter, Azenta US Inc, Singapore
Networking
6:15pm - 7:45pm
Exhibits and Posters Networking Reception, and Poster Gallery Walk
Join us for a networking evening in the exhibit hall where you can connect with colleagues and exhibitors, and peruse the abstract posters. Poster presenters will be at their posters to network with delegates.
THURSDAY, April 23 - JOINT DAY WITH BBCMBA
5km Fun Run/Walk
6:00am - 7:00am
This year, delegates are invited to enjoy a self-paced run or walk along a picturesque beachwalk path recommended by the local organizers, offering scenic views of the water on one side and the vibrant city on the other. The Fun Run/Walk is a free, self-reliant activity designed to bring ISBER and BBCMBA delegates together for a fun outdoor networking experience; A refreshing start to the joint ISBER-BBCMBA day! Participants can purchase a collectible ISBER athletic t-shirt, featuring the iconic dancing ISBER letters customized with local emblems, celebrating the spirit and energy of our host country. Order your t-shirt when registering or purchase it here.
8:00am - 8:30am
Joint Welcome Remarks
KEYNOTE LECTURE
8:30am - 9:15am
Keynote Lecture by Dr Gao
KEYNOTE LECTURE
9:15am - 10:00am
10 years of BCNet: Driving global collaboration in Biobanking, Dr. Zisis Kozlakidis, PhD, MBA, International Agency For Research On Cancer/World Health Organization, France
Over the past decade, the Biobank and Cohort Building Network (BCNet) has transformed the global landscape of biobanking by fostering cooperation, capacity-building, and shared expertise among low- and middle-income
countries (LMICs). Established as an IARC/WHO initiative, BCNet arose from a clear need: to strengthen the infrastructure, quality, and governance of biobanks so that all nations—regardless of resources—can
contribute to and benefit from biomedical research. Over ten years, the network has grown into a vibrant international community that bridges scientific, geographic, and economic divides.
BCNet’s
achievements are grounded in three pillars: training, standardisation, and partnership. Through targeted workshops, technical exchanges, and mentorship programmes, the network has empowered institutions to develop
high-quality biospecimen resources aligned with international standards. This effort has helped harmonise procedures, improve data integrity, and enable cross-border studies that were previously out of reach
for many LMIC researchers. In parallel, BCNet has provided a trusted platform for dialogue on ethics, governance, and equitable benefit sharing—critical elements for ensuring public trust and long-term sustainability.
A defining feature of BCNet’s first decade is its emphasis on collaboration rather than competition. By connecting biobanks, research centres, ministries of health, and global partners, the network has
catalysed joint projects on cancer research and population health. These collaborations have strengthened national research ecosystems and amplified LMIC contributions to global health innovation.
As
BCNet enters its next decade, it stands as a model of how coordinated international action can build capacity, promote scientific equity, and accelerate discoveries that benefit populations worldwide.
10:00am - 10:30am
Morning Break
BBCMBA Session
10:30am - 12:00pm
BBCMBA Morning Session
12:30pm - 1:30pm
General Lunch, Posters, and Exhibits
Joint Session CONCURRENT with Contributed Paper Session 11
1:30pm - 2:30pm
Joint Session 1 - Organoids
Presenters from ISBER:
V Krishnan Ramanujan, Cedars Sinai, USA
Jun Mei Zhou, Shanghai Children Hospital, China
SESSION 11 - People, Policy & Biobanking
Multiomics and Tumor Banking: A Comprehensive Platforms Integrating Cancer Diversity, Biomarker Discovery, and Personalized Cancer Care Abhishek Mohanty, HealthCare Global Enterprises Ltd,
India
Streamlining Specimen Inventory Management at the NSW Health Statewide Biobank - A Five-Year Review Yingshi Li, New South Wales Health Pathology, Australia
Joint Session CONCURRENT with Flash Talks
2:30pm - 3:30pm
Joint Session 2 - Artificial Intelligence (AI)
Presenters from ISBER:
Gregory Grossman, Advancing Sight Network/Precision Ocular Biobank, USA
Zisis Kozlakidis, International Agency For Research On Cancer/World Health Organization, France
Dr Zisis Kozlakidis, PhD, MBA, International Agency For Research On Cancer/World Health Organization (IARC/WHO), France
Dr Zisis Kozlakidis is the Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer, World Health Organization (IARC/WHO). He is responsible for one of the largest and most varied
international collections of clinical samples in the world, focusing on gene - environment interactions and disease-based collections, and director of the LMIC-focused Biobank and Cohort building network. These
WHO infrastructures support multinational research efforts in making treatments possible and delivering those to resource-restricted settings.
Dr SU Xinying, MD, PhD, Development China, Pfizer, China
Xinying Su is an accomplished leader in translational medicine, specializing in bridging scientific innovation with clinical application to accelerate drug development and improve patient outcomes. With extensive experience
in diagnostics and precision medicine, Xinying drives strategies that integrate biomarker research, clinical trial design, and regulatory compliance to support drug development. Dr. Su holds an MD from Shanghai
Jiao Tong University and a PhD in Oncology from Paris 7 University , with 30+ publications in translational and clinical diagnostics.
Prof CHEN Wan-Tao, Md, PhD, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, China
Prof. Chen serves as President of the Shanghai Institute of Stomatology and as Deputy Chair of the Department of Oral and Maxillofacial Surgery at Shanghai Ninth People's Hospital. He also leads the Shanghai Professional
Technical Service Platform-Sharing Platform for the Tissue Sample and Bioinformatics Database of Oral Cancer. His clinical and research expertise is centered on cancers, with a specialized focus on establishing
and application biobank of head and neck cancer. As a principal investigator, he has secured substantial competitive funding, including 14 national and international grants. He has published over 110 papers in internationally
renowned professional journals.
Late-breaking Abstract Submission period (for poster abstracts only): January 7 -21, 2026
The submission link will be added to this section on January 7, 2026. Check back soon!
In 2026, the majority of the scientific program will be driven by abstract submissions from the global community. This creates an exciting opportunity for you to shape the conversation and showcase your work on a global stage.
Please note that all accepted abstracts presenters are expected to register by the early bird deadline and to attend the conference. Abstract presenters will be responsible for their own meeting-related expenses, including
registration, accommodations, and travel.
For the full list of abstract submission guidelines, please click here. Please ensure you carefully review
the submission guidelines and the formatting instructions before you submit your abstract.
Workshop proposal submissions period: August 20 - November 12, 2025* (*extended to November 26)
ISBER is pleased to accept workshop proposal submissions for the 2026 ISBER Biobanking Congress. All workshop submitters should review the workshop proposal submission guidelines prior to completing their submission.
What's a workshop? A workshop is a long interactive meeting or educational session designed to create a specialized result. The workshop presenter(s) design the sequence of presentations, plan collaborative
activities, and ensure the workshop will lead to the desired result.
Please note that all accepted workshop presenters are expected to register by the early bird deadline and to attend the conference. Workshop presenters will be responsible for their own meeting-related expenses, including
registration, accommodations, and travel.
Accepted workshop presenters may be asked to submit their presentation slides in advance of the meeting for review. Head Office will provide more information on this closer to the meeting.
Product advertisements are not appropriate for presentation. If you wish to host a corporate session, please see our corporate opportunities. Email sponsorship@isber.org for more information.
For the full list of workshop submission guidelines, please click here. Please ensure you carefully review
the guidelines before you submit your workshop.
*Extended* Submission Deadline: November 26, 2025 at 11:59pm North America Eastern Time.
Roundtable discussion submission period: August 20 - November 12, 2025
ISBER is pleased to accept roundtable discussion submissions for the 2026 ISBER Biobanking Congress in Shenzhen, China. Roundtable discussions are an opportunity to get together with fellow delegates to discuss an important topic
or challenge in biobanking in an informal setting. Submit a proposal to facilitate a discussion on this topic at the in-person congress in Shenzhen, China.
What's a Roundtable Discussion? Roundtable sessions feature a group of presenters who will make brief, informal remarks about a specific idea or topic. They allow for extensive discussion and audience
participation. These sessions can take many forms, with presenters delivering prepared statements or diving straight into questions from the moderator or audience. Regardless of format, they’re designed to elicit an exchange
of viewpoints among the experts on a topic. Please ensure this is discussion-driven and not presentation-heavy.
Past RoundTable Discussion topics include, but are not limited to:ISO20387 Systematic Review; Biobanking as an Informatics Problem; Evaluating and selecting the right packing materials for shipments; Benefits of Accreditation
for Biobanking; Ethical Principles for International Biospecimen and Data Sharing; Challenges and solutions for clinical sites engaged in cancer biobanking; Striking the Balance: Tissue triage of rare diseases to balance the
biospecimen demands of clinical care, molecular trials and discovery research; and many more.
Please note that all accepted rountable discussion facilitators are expected to register by the early bird deadline and to attend the ISBER Congress. Facilitators will be responsible for their own meeting-related expenses,
including registration, accommodations, and travel.
Submission Deadline: November 12, 2025 at 11:59pm North America Eastern Time.
BGI Center, No.9 Yunhua Road, Yantian District, Shenzhen, 518085, China (华大时空中心)
HOTEL OPTIONS
Our local partner provided a list of recommended hotels with varying price ranges. All hotels are located approximately 10–15 minutes by car from the congress venue.
Kingkey Palace Hotel 大梅沙京基海湾大酒店
Average price per night: $90 US
Star Rating: 8.2/10 on Booking.com
Address: 90 Yan Kui Lu, Yantian District, Shenzhen, GD, China, 518083
If you require a visa to travel to China, ISBER strongly recommends that you begin your visa application at least three (3) months prior to your intended date of entry. Visa processing times can vary significantly depending on your nationality, location, and time of year, and delays are common.
General information on Chinese visas and application procedures is available through the official Chinese Visa Application Service Center:
If you require an invitation (visa support) letter from ISBER to support your visa application, you must first complete your meeting registration.
Once registered, check your confirmation email which includes a link and instructions on how to request a visa support letter.
Visa-Free and Transit-Without-Visa Entry
Some travelers may be eligible for visa-free entry or visa-free transit into China under specific conditions (including nationality, length of stay, ports of entry, and onward travel to a third country). Please carefully review eligibility requirements using official sources: this article and the official site of China Consular Affairs.
Resources for U.S. Citizens
Delegates traveling on a U.S. passport are encouraged to consult the following official resources for the most up-to-date guidance, including visa-free transit policies and entry requirements:
Please note that eligibility for visa-free transit (including 24-hour, 72-hour, 144-hour, or extended transit stays) depends on your specific itinerary and ports of entry and exit. Travelers are responsible for confirming their eligibility prior to departure.
Important Reminder
Visa regulations are subject to change. ISBER strongly advises all delegates to verify requirements with the appropriate Chinese consulate or official government sources well in advance of travel.
The Sponsor & Exhibitor Prospectus for the ISBER 2026 Global Biobanking Congress in Shenzhen, China is now available. Explore a range of sponsorship and exhibition opportunities designed to maximize your visibility
and engagement with the global biobanking community. For marketing opportunities, guidelines and policies, please visit the dedicated Sponsorship Opportunities webpage.
Exhibit spaces are allocated on a first-come, first-served basis. Please indicate your top three booth location preferences in the application form. To apply, complete the fillable PDF form at the end of the prospectus
and return it to sponsorship@isber.org.
2025 Sponsors and Exhibitors
For the full list of 2025 sponsors, browse our PDF program here.
Creating the Program for the ISBER Global Biobanking Congress
Communicating with speakers who have been invited to the annual meeting, organizing the review of submitted abstracts, recommending and inviting co-chairs for each session of the annual meeting, and arranging various other details associated with the
meeting
Task Force Co-Chairs:
Deb Leiolani Garcia, MPA Independent Consultant United States
Ms. Deb Leiolani Garcia has been working in the field of biobanking for over 25 years. She earned her B.S. in Microbiology from San Francisco State University and an M.P.A. in Public Administration from University of California,
Berkeley. She served as the Operations Director of the NCI funded Central Operations and Data Coordinating Center (CODCC) of the AIDS and Cancer Specimen Resource (ACSR), a multi-site biobanking program which included 5 U.S.
academic biorepositories and 1 located in South Africa. She has been an active member of the International Society for Biological and Environmental Repositories (ISBER) since 2000 serving in the president’s group for 3 years
and currently is serving as the chair of the Rising Stars: Next Generation Biobankers and co-chair of the Biobank Awareness Task Force and Biobanking 101 and 201 workshops. Ms Garcia is also an active member of the Association
of Southeast Asian Nations (ASEAN) Biobanking Feasibility Study Advisory Group. The focus of this group is to provide training on biorepository operational management, regulatory and ethical practices, and integration of biobanking
best practices focused on the standardization and harmonization of protocols and procedures in the Southeast Asia region. She is a co-author of 24 peer-reviewed articles and book chapters in biobanking operational and regulatory
management.
Jason Chen, BS BGI Research China
Jason Chen is a results-driven leader with extensive expertise spanning over two decades in team management, project coordination, and strategic partnership development within global genomics, biobanking, national laboratories,
hospitals, academic institutions, museums, and other biotechnology sectors. He is internationally recognized as an ISO/TC 276 Biotechnology Expert, serves as ISBER Director-at-Large for the China Region, and is an Executive
Committee Member of the Global Genome Biodiversity Network (GGBN). Throughout his distinguished career, Jason has held prominent roles, including Assistant Director at China National GeneBank (BGI), Director of Business Development
and Senior Research Operations Manager at Complete Genomics, Inc., and Sponsored Programs Analyst at the San Jose State University Research Foundation. He holds a degree from the University of California, Davis. Jason has successfully
spearheaded the planning and execution of numerous high-profile international initiatives, notably the ISBER 2019 Annual Meeting and Exhibits, the Annual Biobank China 2018 (ABC 2018), the International Symposium on Data Intelligence
in Life Science, and the GGBN 2017 Regional Asian Workshop. His leadership in these endeavors has significantly advanced collaboration and innovation within the global scientific community.
Task Force Members:
Dan Catchpoole, BSc(Biomed), PhD (UNSW), FFSc(RCPA) Kids Research, The Children's Hospital at Westmead Australia
Io Hong Cheong, PhD School of Public Health, Shanghai Jiao Tong University School of Medicine China
Jelani Clarke, PhD AminoChain Canada
Asim Farooq Pakistan Kidney and Liver Institute and Research Center Pakistan
Marianne Henderson, MS CPC PMP National Cancer Institute United States
Henry Hong Jiangsu SERLNG Life Science China
Yuqing Ji Huashan Hospital, Fudan University China
Julia(Huijie) Jiang Huashan Hospital, Fudan University China
Louise Ludlow Murdoch Children's Research Institute Australia
Anna Michalska-Falkowska, PhD Medical University of Bialystok Poland
Adelina Ovcharenko, PhD MIDGAM Israel
Karena Pryce University of Sydney Australia
V Krishnan Ramanujan, PhD, MS Cedars Sinai United States
Hans Sathasivam, PhD Ministry of Health Malaysia Malaysia
Purnima Singh, PhD University of Alabama at Birmingham United States
Rajeev Singh, MD, MBA Georgia Cancer Center Biorepository, Augusta United States
Yan Ru Su PhD Vanderbilt University Medical Center United States
Wayne Wang Origincell / Orcella Instruments United States and China
Qiu Xiu, PhD Guangzhou Women and Children's Medical Center China
Ying Yan Yu, PhD Jiaotong University School of Medicine, Shanghai China
ISBER is delighted to welcome you to the city of Shenzhen, China. Shenzhen is a coastal city in South China’s Guangdong Province. It is located on the eastern bank of the Pearl River, neighboring Guangzhou to the west and Hong Kong to the south.
Shenzhen has transformed from a tiny border town with a population of roughly 30,000 in the 1970s into a metropolis with a population of more than 17 million. It has become a prosperous, chic, innovative, harmonious and beautiful city, a pioneer in many fields of global industrialization, urbanization and modernization.
Shenzhen serves as a link between the Chinese mainland and Hong Kong and a transport hub for coastal southern China. The city leads in high-tech development, financial services, foreign trade, shipping and creative and cultural industries. Explore the city, check out the recommended practical information, plan your travels, and extend your stay! Visit theShenzhen's official travel website for travel information. This travel guide may also provide additional tips for your travels.
Youtube videos are another great source of information from travelers who have explored the city and region, such as the below.
Getting Around Shenzhen
ISBER recommends using DiDi for transportation while in Shenzhen. Navigating the city can be challenging without Mandarin, and DiDi, China’s leading ride-hailing app, offers an English interface and a range of vehicle options. For guidance on using the app, seehow to use DiDi in China.
Deb Leiolani Garcia, MPA
Jason Chen, BS